PUFAs in Preterm Infants

ConditionsNecrotizing Enterocolitis Intraventricular Hemorrhage BPD - Bronchopulmonary Dysplasia Sepsis Periventricular Leukomalacia Patent Ductus Arteriosus

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorThe First Hospital of Jilin University

About this trial

The research endeavors to examine the critical composition of Polyunsaturated Fatty Acids (PUFAs) in premature infants across different gestational stages and under varying disease conditions, and delineate the metabolic attributes of PUFAs in premature infants and their interplay with the onset of diseases. This study anticipates furnishing a theoretical foundation for the rationalization of PUFAs supplementation in premature infants and for informing strategies related to disease prevention and management.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

The First Hospital of Jilin University

Lead sponsor

Source ClinicalTrials.gov